Facebook Twitter Youtube Vk Rss
Facebook Twitter Youtube Vk Rss
  Trending
Telesis Bio Reports Record Q4 Revenues March 22, 2023
JanOne Sells ARCA Recycling to Focus on Growing BioPharm Businesses March 22, 2023
Vistagen Announces Positive Phase 3 Data March 22, 2023
89bio Reports Positive Phase 2b Results March 22, 2023
Virgin Orbit Reportedly near closing $200 Million Private Placement March 22, 2023
Next
Prev

UPDATE-(NASDAQ: NRSN) shares are moving up again more than 31% today on news of positive preliminary results from Alzheimer’s Biomarker Study.

  • Jun 30, 2022 at 10:02 AM

Shares are $3.64 on more than 33 million in volume and closing in on 92,000 trades one hour after the open.

NeuroSense Therapeutics Reports Positive Preliminary Results from Novel Alzheimer’s Biomarker Study USA – English 

https://www.prnewswire.com/il/news-releases/neurosense-therapeutics-reports-positive-preliminary-results-from-novel-alzheimers-biomarker-study-301578686.html

CAMBRIDGE, Mass., June 30, 2022 /PRNewswire/ — NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) (“NeuroSense”), a company developing treatments for severe neurodegenerative diseases, today announced results from a biomarker study conducted to evaluate the potential of CogniC, NeuroSense’s combination drug for the treatment of Alzheimer’s disease (AD).

RelatedNews

Page 1 of 3
123

Want more news like this? Check out our homepage!

Signup today for free and be the first to get notified of breaking news.

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Recent News

Follow Us

Facebook-f Twitter Youtube

SIGN UP FOR OUR NEWSLETTER

Sign up for Breaking Alerts, our newsletter putting timely and updated stock and crypto markets news into your hands.

24/7 MarketNews is a leading market news platform for public companies. As a pioneer in digital media, we are dedicated to the swift distribution of financial market news and information. We take great pride in creating innovative public relations campaigns that help our clients reach their target audience.

Search by keyword

© 2022-2023 24/7MarketNews – The Experts in Investor and Public Relations

Add New Playlist

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.